AAAAAA
Results:
1-9
|
Results: 9
Authors:
THOMAS P
MARON M
RASCLE C
COTTENCIN O
VAIVA G
GOUDEMAND M
Citation: P. Thomas et al., CARBAMAZEPINE IN THE TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME, Biological psychiatry, 43(4), 1998, pp. 303-305
Authors:
THOMAS P
RASCLE C
MASTAIN B
MARON M
VAIVA G
Citation: P. Thomas et al., TEST FOR CATATONIA WITH ZOLPIDEM, Lancet, 349(9053), 1997, pp. 702-702
Authors:
THOMAS P
ROCHE J
MARON M
COTENCIN O
VAIVA G
GOUDEMAND M
Citation: P. Thomas et al., SEVERE EXTRAPYRAMIDAL SYMPTOMS WITH FLUVOXAMINE DESPITE NEUROLEPTICS WITHDRAWAL, European psychiatry, 11(5), 1996, pp. 273-273
Authors:
ODOU P
VAIVA G
LUYCKX M
BRUNET C
DINE T
GRESSIER B
CAZIN M
CAZIN J
Citation: P. Odou et al., NEUROLEPTIC MONITORING - RELATION BETWEEN ANTIPSYCHOTIC EFFICIENCY AND RADIORECEPTOR ASSAY OF SERUM HALOPERIDOL, European Journal of Clinical Pharmacology, 50(5), 1996, pp. 357-363
Authors:
MASTAIN B
VAIVA G
GUEROUAOU D
POMMERY J
THOMAS P
Citation: B. Mastain et al., DRAMATIC IMPROVEMENT OF CATATONIA WITH ZO LPIDEM, Revue neurologique, 151(1), 1995, pp. 52-56
Authors:
VAIVA G
THOMAS P
LEROUX JM
COTTENCIN O
DUTOIT D
ERB F
GOUDEMAND M
Citation: G. Vaiva et al., RED-BLOOD-CELL SUPEROXYDE DISMUTASE IN PO SITIVE PSYCHOSIS, Therapie, 49(4), 1994, pp. 343-348
Authors:
DUTOIT D
LEROUX JM
VAIVA G
MOHAMED Y
THOMAS P
POMMERY J
TARET I
BIANCHIDECAIX I
ERB F
GOUDEMAND M
Citation: D. Dutoit et al., RED-BLOOD-CELLS HALOPERIDOL REDUCTASE-ACT IVITY - INTEREST IN THE INITIATION OF HALOPERIDOL TREATMENT, Therapie, 49(1), 1994, pp. 71-74
Authors:
THOMAS P
LALAUX N
VAIVA G
GOUDEMAND M
Citation: P. Thomas et al., DOSE-DEPENDENT STUTTERING AND DYSTONIA IN A PATIENT TAKING CLOZAPINE, The American journal of psychiatry, 151(7), 1994, pp. 1096-1096
Authors:
THOMAS P
VAIVA G
SAMAILLE E
MARON M
ALAIX C
STEINLING M
GOUDEMAND M
Citation: P. Thomas et al., CEREBRAL BLOOD-FLOW IN MAJOR DEPRESSION AND DYSTHYMIA, Journal of affective disorders, 29(4), 1993, pp. 235-242
Risultati:
1-9
|